STXBP4 Antibody

What is STXBP4 and why are antibodies against it important in research?

STXBP4 (Syntaxin Binding Protein 4) is a cytoplasmic protein that plays a critical role in the translocation of transport vesicles from the cytoplasm to the plasma membrane. In humans, the canonical STXBP4 protein consists of 553 amino acid residues with a molecular mass of approximately 61.7 kDa . This protein has up to two different isoforms and is widely expressed across various tissue types. STXBP4 is also known by other names including Synip, STX4-interacting protein, and syntaxin 4 interacting protein .

Antibodies against STXBP4 are particularly important in research because they enable scientists to study the protein's expression patterns, localization, interactions, and functional roles in normal and pathological conditions. Recent studies have revealed that STXBP4 is involved in functional gene networks regulating cell growth, proliferation, cell death, and survival in cancer . Additionally, research has demonstrated that STXBP4 regulates ΔNp63 ubiquitination, suggesting its potential role as a biomarker in squamous cell carcinoma (SCC) . The ability to accurately detect and quantify STXBP4 using specific antibodies therefore provides researchers with valuable tools for understanding fundamental cellular processes and disease mechanisms.

What are the main applications of STXBP4 antibodies in laboratory research?

STXBP4 antibodies serve multiple purposes in laboratory research across various experimental platforms. The primary applications include:

Western Blot (WB): STXBP4 antibodies are widely used in Western blotting to detect and quantify STXBP4 protein levels in cell and tissue lysates. This technique allows for the determination of protein expression levels and can reveal changes in response to experimental conditions or disease states . The observed molecular weight by Western blot is approximately 62 kDa .

Immunohistochemistry (IHC): STXBP4 antibodies are employed in IHC to visualize the spatial distribution of STXBP4 in tissue sections. This application is particularly valuable for comparing expression patterns between normal and pathological tissues, such as in cancer studies . For paraffin-embedded tissues, dilutions typically range from 1:20 to 1:200 .

Immunofluorescence (IF): For subcellular localization studies, STXBP4 antibodies can be used in immunofluorescence assays to determine the precise localization of the protein within cells. This technique has been validated in cell lines such as BxPC-3 .

Enzyme-Linked Immunosorbent Assay (ELISA): STXBP4 antibodies can be utilized in ELISA to quantitatively measure STXBP4 levels in solution, providing a high-throughput method for protein quantification .

Co-immunoprecipitation (Co-IP): STXBP4 antibodies enable the study of protein-protein interactions through co-immunoprecipitation assays, helping researchers understand STXBP4's role in various cellular pathways and complexes.

How can I validate the specificity of a STXBP4 antibody?

Validating antibody specificity is crucial for ensuring reliable experimental results. For STXBP4 antibodies, a multi-faceted validation approach is recommended:

Positive and Negative Controls:

• Use cell lines or tissues known to express high levels of STXBP4 (such as BxPC-3 cells, PC-3 cells, or human heart tissue) as positive controls .

• Use knockout or knockdown models (STXBP4 siRNA or shRNA-treated cells) as negative controls to confirm specificity.

Multiple Detection Methods:

• Compare results across different detection techniques (WB, IHC, IF) to ensure consistent findings .

• In Western blotting, verify that the detected band appears at the expected molecular weight (approximately 62 kDa for STXBP4) .

Cross-Reactivity Assessment:

• Test the antibody against samples from different species if the antibody claims cross-reactivity (human, mouse, rat) .

• Perform peptide competition assays where pre-incubation of the antibody with the immunizing peptide should abolish or significantly reduce signal.

Orthogonal Validation:

• Correlate protein detection with mRNA expression data from qPCR or RNA-seq experiments.

• Use multiple antibodies targeting different epitopes of STXBP4 to confirm findings.

Experimental Validation Table:

What are the recommended protocols for using STXBP4 antibodies in Western blotting?

For optimal Western blot results with STXBP4 antibodies, the following protocol recommendations should be considered:

Sample Preparation:

• Extract proteins using a lysis buffer containing protease inhibitors to prevent degradation (e.g., Complete protease inhibitor cocktail) .

• Include phosphatase inhibitors (e.g., 1 mM Na3VO4) if studying phosphorylated forms of STXBP4 .

• Homogenize samples thoroughly by passage through a needle (e.g., 20G) to ensure complete lysis .

Protein Separation:

• Load 20-50 μg of total protein per lane on 8-10% SDS-PAGE gels.

• Include positive control samples (e.g., BxPC-3 cells, PC-3 cells, human heart tissue) .

• Use a molecular weight marker to verify the expected size of STXBP4 (~62 kDa).

Transfer and Detection:

• Transfer proteins to nitrocellulose membranes at 100V for 60-90 minutes .

• Block membranes with 5% non-fat milk or 5% BSA in TBST for 1 hour at room temperature.

• Dilute primary STXBP4 antibody at 1:500-1:5000 in blocking buffer based on the specific antibody recommendation .

• Incubate with primary antibody overnight at 4°C.

• Wash membranes 3-5 times with TBST, 5 minutes each.

• Incubate with appropriate HRP-conjugated secondary antibody (typically 1:5000-1:10000) for 1 hour at room temperature.

• Wash membranes 3-5 times with TBST, 5 minutes each.

• Develop using enhanced chemiluminescence (ECL) detection system.

Optimization Tips:

• If background is high, increase washing time or detergent concentration.

• For weak signals, increase antibody concentration or extend primary antibody incubation time.

• Include β-Actin as a loading control to normalize protein levels .

What are the best fixation and staining methods for STXBP4 immunohistochemistry?

Successful immunohistochemical detection of STXBP4 requires careful attention to fixation, antigen retrieval, and staining procedures:

Tissue Preparation and Fixation:

• Formalin-fixed, paraffin-embedded (FFPE) tissue sections are commonly used for STXBP4 IHC .

• Fix tissues in 10% neutral buffered formalin for 24-48 hours.

• Process and embed in paraffin according to standard protocols.

• Section tissues at 4-5 μm thickness for optimal staining.

Antigen Retrieval:

• Deparaffinize sections in xylene and rehydrate through graded alcohols to water.

• Perform heat-induced epitope retrieval (HIER) using citrate buffer (pH 6.0) or EDTA buffer (pH 9.0).

• Heat sections in retrieval buffer for 15-20 minutes using a pressure cooker, microwave, or water bath.

• Allow sections to cool to room temperature before proceeding.

Staining Procedure:

• Block endogenous peroxidase activity with 3% hydrogen peroxide for 10 minutes.

• Block non-specific binding using 5% FBS in PBS for 1 hour at room temperature .

• Apply primary STXBP4 antibody at a 1:20-1:200 dilution (optimize for specific antibody) .

• Incubate overnight at 4°C in a humidified chamber .

• Wash sections with PBS three times, 5 minutes each.

• Apply appropriate biotinylated secondary antibody and develop using Vectastain universal ABC Kit and DAB Kit .

• Counterstain nuclei with Meyer's hematoxylin .

• Dehydrate, clear, and mount sections with permanent mounting medium.

Evaluation Method:

• Score STXBP4 expression using a semi-quantitative method as described in the literature:

  • 1 ≤ 10% positive cells

  • 2 = 10-25% positive cells

  • 3 = 25-50% positive cells

  • 4 = 51-75% positive cells

  • 5 ≥ 75% positive cells

• Classify tumors with scores of 3, 4, or 5 as STXBP4-positive; scores of 1 and 2 as STXBP4-negative .

How does STXBP4 interact with the ΔNp63 signaling pathway in cancer biology?

STXBP4 plays a significant role in cancer biology through its interaction with the ΔNp63 signaling pathway, particularly in squamous cell carcinoma (SCC). Research has revealed several key aspects of this interaction:

Regulation of ΔNp63 Stability:
STXBP4 regulates ΔNp63 ubiquitination, which affects the protein's stability and accumulation in cells . In lung SCC specimens, significantly higher levels of STXBP4 expression correlate with accumulations of ΔNp63 (Spearman's rank correlation ρ=0.219) . This regulatory mechanism suggests that STXBP4 may prevent the degradation of ΔNp63, leading to its accumulation in cancer cells.

Clinical Correlations in SCC:
STXBP4-positive tumors correlate with three important clinical parameters in lung SCC:

• T factor (P<0.001)

• Disease stage (P=0.030)

• Pleural involvement (P=0.028)

These correlations indicate that STXBP4 expression may influence tumor growth and invasion properties.

Downstream Signaling Pathways:
Whole transcriptome sequencing followed by pathway analysis has indicated that STXBP4 is involved in functional gene networks that regulate cell growth, proliferation, cell death, and survival in cancer . Notably, Platelet-Derived Growth Factor Receptor alpha (PDGFRα) has been identified as a key downstream mediator of STXBP4 function .

Functional Effects in Cancer Models:
shRNA-mediated knockdown of STXBP4 suppresses tumor growth in soft agar and xenograft assays, similar to the effects observed with ΔNp63 knockdown . This suggests that STXBP4 contributes to the oncogenic properties of SCC, possibly through its regulation of ΔNp63 and downstream effectors like PDGFRα.

Methodology for Studying STXBP4-ΔNp63 Interactions:
To investigate these interactions, researchers can:

• Perform co-immunoprecipitation assays using STXBP4 antibodies to pull down protein complexes and detect ΔNp63.

• Use proximity ligation assays to visualize protein-protein interactions in situ.

• Conduct ubiquitination assays to assess how STXBP4 affects ΔNp63 ubiquitination status.

• Employ RNA-seq and pathway analysis to identify genes and pathways regulated by the STXBP4-ΔNp63 axis.

What strategies can be employed to detect different STXBP4 isoforms using antibodies?

The detection of specific STXBP4 isoforms presents challenges that require strategic approaches:

Understanding STXBP4 Isoforms:
Up to two different isoforms have been reported for STXBP4 . Distinguishing between these isoforms is important for understanding their potentially different functions and tissue-specific expression patterns.

Epitope-Specific Antibodies:

• Select antibodies raised against epitopes that are unique to specific isoforms.

• Use antibodies generated against recombinant proteins representing full-length or specific domains of STXBP4 isoforms.

• For commercially available antibodies, carefully review the immunogen information to determine which regions of STXBP4 the antibody recognizes.

High-Resolution Protein Separation:

• Employ gradient gels (e.g., 4-15%) to achieve better separation of closely sized isoforms.

• Consider using Phos-tag™ SDS-PAGE to separate phosphorylated from non-phosphorylated forms, which may help distinguish post-translationally modified isoforms.

• Use 2D gel electrophoresis to separate isoforms based on both molecular weight and isoelectric point.

Complementary Detection Methods:

• Combine antibody-based detection with mass spectrometry for definitive isoform identification.

• Perform RT-PCR with isoform-specific primers to correlate protein detection with mRNA expression.

• Use isoform-specific siRNAs to selectively knockdown individual isoforms and confirm antibody specificity.

Verification Strategies:

• Express recombinant tagged versions of each isoform in cell models and use both anti-tag and anti-STXBP4 antibodies to confirm detection.

• Use tissues or cell lines known to preferentially express specific isoforms as positive controls.

• Perform peptide competition assays with isoform-specific peptides to confirm antibody selectivity.

Troubleshooting Isoform Detection:

How can phospho-specific STXBP4 antibodies be used to study post-translational modifications?

Phosphorylation is a key post-translational modification of STXBP4 that can alter its function, localization, and interactions . Phospho-specific antibodies provide valuable tools for studying these modifications:

Generation of Phospho-Specific Antibodies:

• Identify key phosphorylation sites in STXBP4 through phosphoproteomic studies or predictive algorithms.

• Generate antibodies against synthetic phosphopeptides containing the phosphorylation site(s) of interest.

• Ensure specificity by testing against both phosphorylated and non-phosphorylated peptides.

Experimental Applications:

• Signaling Pathway Analysis:

  • Use phospho-specific antibodies to monitor STXBP4 phosphorylation in response to different stimuli or inhibitors.

  • Combine with inhibitors of specific kinases to identify the kinases responsible for STXBP4 phosphorylation.

  • Compare phosphorylation patterns in normal versus disease states to identify pathological alterations.

• Phosphorylation Dynamics:

  • Perform time-course experiments to track changes in STXBP4 phosphorylation following cell stimulation.

  • Use in conjunction with general STXBP4 antibodies to determine the proportion of phosphorylated protein.

  • Combine with subcellular fractionation to determine if phosphorylation affects localization.

• Structure-Function Relationships:

  • Correlate phosphorylation status with STXBP4 binding to partners like syntaxin 4 or ΔNp63.

  • Use phospho-mimetic and phospho-dead mutants in functional assays to determine the impact of phosphorylation.

  • Employ proximity ligation assays to visualize how phosphorylation affects protein-protein interactions in situ.

Methodological Considerations:

• Sample Preparation: Include phosphatase inhibitors (e.g., sodium orthovanadate, sodium fluoride, β-glycerophosphate) in lysis buffers to preserve phosphorylation states .

• Validation Controls: Use lambda phosphatase treatment of parallel samples as negative controls.

• Detection Optimization: For Western blots, blocking with BSA rather than milk is often preferred as milk contains casein phosphoproteins that can interfere with phospho-antibody binding.

• Multiplexing: Use differently labeled secondary antibodies to simultaneously detect phosphorylated and total STXBP4 on the same blot.

Relation to Disease States:
Altered phosphorylation of STXBP4 may contribute to disease mechanisms, particularly in cancer where abnormal signaling is common. Phospho-specific antibodies can help reveal how changes in STXBP4 phosphorylation contribute to cancer progression, potentially identifying new therapeutic targets.

What is the role of STXBP4 in cancer progression and prognosis?

Research has revealed significant associations between STXBP4 expression and cancer biology, particularly in lung squamous cell carcinoma (SCC):

Oncogenic Functions:
STXBP4 drives tumor growth through several mechanisms:

• Regulation of ΔNp63 stability through modulation of ubiquitination

• Involvement in functional gene networks that regulate cell growth, proliferation, cell death, and survival

• Activation of downstream signaling through PDGFRα, which acts as a key mediator of STXBP4 function

Clinical Correlations and Prognostic Value:
STXBP4 expression has been associated with several clinicopathological parameters in lung SCC:

These findings suggest that STXBP4 serves as an independent prognostic factor for predicting worse outcomes in lung SCC.

Experimental Evidence:
Functional studies support STXBP4's role in cancer:

• shRNA-mediated knockdown of STXBP4 suppresses tumor growth in soft agar assays

• STXBP4 knockdown inhibits tumor formation in xenograft models

• Similar growth inhibition is observed with PDGFRα knockdown, suggesting it is a key downstream effector

Methodological Approaches for Studying STXBP4 in Cancer:

• Expression Analysis:

  • Use immunohistochemistry with validated STXBP4 antibodies to assess expression in tissue microarrays

  • Score expression using semi-quantitative methods (as detailed in section 1.5)

  • Correlate expression with clinical parameters and survival data

• Functional Studies:

  • Generate stable knockdown or knockout cell lines using shRNA or CRISPR/Cas9

  • Perform gain-of-function studies with STXBP4 overexpression

  • Assess effects on proliferation, migration, invasion, and apoptosis

  • Conduct in vivo tumorigenicity assays using xenograft models

• Pathway Analysis:

  • Use RNA-seq to identify genes and pathways affected by STXBP4 manipulation

  • Perform protein interaction studies to identify STXBP4 binding partners in cancer cells

  • Investigate downstream signaling events, particularly focusing on PDGFRα activation

Therapeutic Implications:
The involvement of STXBP4 in cancer progression suggests it may be a relevant therapeutic target for patients with lung SCC . Strategies might include:

• Developing inhibitors of STXBP4-ΔNp63 interaction

• Targeting downstream pathways such as PDGFRα signaling

• Using STXBP4 expression as a biomarker for patient stratification in clinical trials

How can STXBP4 antibodies be optimized for co-immunoprecipitation experiments?

Co-immunoprecipitation (Co-IP) is a valuable technique for studying protein-protein interactions involving STXBP4. Optimizing STXBP4 antibodies for this application requires careful consideration of several factors:

Antibody Selection:

• Choose antibodies that recognize native (non-denatured) STXBP4, as Co-IP requires antibodies that bind to proteins in their native conformation.

• Consider using antibodies targeting different epitopes to ensure the binding site does not interfere with protein-protein interactions.

• Polyclonal antibodies often work well for Co-IP due to their recognition of multiple epitopes .

Lysis Buffer Optimization:

• Use non-denaturing lysis buffers that preserve protein-protein interactions.

• Include protease inhibitors to prevent degradation (e.g., Complete protease inhibitor cocktail) .

• If studying phosphorylation-dependent interactions, include phosphatase inhibitors (e.g., 1 mM Na3VO4) .

• Adjust detergent concentration to balance efficient extraction with preservation of interactions:

  • Start with mild detergents like 0.5-1% NP-40 or Triton X-100

  • For membrane-associated complexes, consider digitonin (0.5-1%)

Pre-clearing and Controls:

• Pre-clear lysates with protein A/G beads to reduce non-specific binding.

• Include appropriate controls:

  • IgG control: Use species-matched non-specific IgG

  • Input control: Save a portion of pre-IP lysate

  • Reverse IP: Immunoprecipitate with antibodies against suspected interaction partners

Antibody Coupling Strategies:

• Direct coupling: Use antibody-conjugated beads for cleaner results

• Indirect coupling: Pre-incubate antibody with lysate before adding protein A/G beads

• Consider crosslinking antibodies to beads to prevent antibody co-elution and contamination

Elution and Detection Methods:

• Gentle elution with peptide competition if available

• Standard elution with SDS sample buffer for Western blot analysis

• For mass spectrometry analysis, consider acid elution or on-bead digestion

Optimization Protocol for STXBP4 Co-IP:

Troubleshooting Common Issues:

• Weak interaction detection: Crosslink proteins before lysis with membrane-permeable crosslinkers

• High background: Increase washing stringency or use different detergent in wash buffer

• Co-IP of unexpected proteins: Validate with reverse IP and ensure antibody specificity

How do results from STXBP4 antibody-based assays correlate with RNA expression data?

Understanding the correlation between protein detection using STXBP4 antibodies and RNA expression data is important for comprehensive molecular profiling and validation of research findings:

Methodological Approaches for Correlation Studies:

• Parallel Analysis Protocols:

  • Extract RNA and protein from the same samples to minimize variability

  • Use RT-qPCR or RNA-seq for mRNA quantification

  • Employ Western blot or IHC with STXBP4 antibodies for protein detection

  • Normalize data appropriately (housekeeping genes for RNA, loading controls for protein)

• Comprehensive Data Analysis:

  • Calculate correlation coefficients (Pearson or Spearman) between mRNA and protein levels

  • Consider time-course experiments to account for temporal differences in mRNA and protein expression

  • Segment analysis by tissue type or disease state to identify context-specific correlations

• Integration with Multi-Omic Data:

  • Correlate with other data types (e.g., microRNA expression, methylation patterns)

  • Perform pathway analysis to understand regulatory mechanisms

  • Use machine learning approaches to identify patterns and predictors of correlation

• Differential gene expression patterns between STXBP4-positive and negative tumors

• Identification of PDGFRα as a key downstream mediator of STXBP4 function

• Correlation between STXBP4 expression and functional gene networks related to cell growth and proliferation

Technical Considerations for Correlation Studies:

Biological Interpretations of Correlations:

• Strong positive correlations suggest predominant transcriptional regulation

• Poor correlations may indicate important post-transcriptional regulation

• Tissue-specific correlation patterns may reveal context-dependent regulatory mechanisms

• Changes in correlation during disease progression can highlight dysregulated processes

An integrated approach using both STXBP4 antibody-based protein detection and RNA analysis provides the most comprehensive understanding of STXBP4's role in normal physiology and disease.